Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  oral complications
Country:  U.S.A.
Trial Type:  Supportive care
Results 1-25 of 26 for your search:
Start Over
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG-0920, NCI-2011-00878, CDR0000651536, NCT01311063, NCT00956007
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: MDA-04-01, NCI-2011-02073, WFU 97115, CDR0000674208, WF-97115, NCT01141231
Glutamine in Reducing the Severity of Mucositis or Esophagitis in Patients with Advanced Cancer Receiving mTOR Inhibitor-Based Chemotherapy or Radiation Therapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: 2013-0308, NCI-2014-00917, NCT01952847
Gabapentin Compared to Usual Care in Preventing Mucositis in Patients with Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 21 and over
Trial IDs: VICC HN 1541, NCI-2015-00750, NCT02480114
Topical Phenylephrine Solution in Preventing Oral Mucositis in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: UW14068, NCI-2015-00576, 2015-0062, NCT02434146
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: IOM-HNC-201-IL, NCI-2015-01924, NCT01400620
Clobetasol Propionate in Treating Patients with Oral Chronic Graft-Versus-Host Disease
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 12 to 99
Trial IDs: 12-C-0068, NCI-2013-01531, P11922, 120068, NCT01557517
Ketamine Hydrochloride in Reducing Pain in Patients With Mucositis Undergoing Chemoradiation or Radiation Therapy For Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: DMS 1022, NCI-2012-01913, D1022, NCT01653327
Personalized Humidification Device in Improving Quality of Life and Reducing Side Effects in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 13-10937, NCI-2013-01745, 072084, 13202, NCT01930435
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients with ER- or PR Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TRIO-US B10, NCI-2013-02384, B-10, 13-001676, TRIO-US, NCT02015559
Topical Sirolimus in Treating Patients with Refractory Oral Chronic Graft-versus-Host Disease
Status: Active
Phase: Phase II
Type: Supportive care
Age: 4 and over
Trial IDs: 14-090, NCI-2014-01564, NCT02123966
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Supportive care
Age: 55 and over
Trial IDs: CLT008-03, NCI-2014-02461, NCT02282215
Phase 2 Study to Evaluate the Safety & Efficacy of Brilacidin Oral Rinse in Patients With Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: CTIX-BRI-205, NCI-2015-01491, NCT02324335
A Mouth Rinse Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: SAN005-01, NCI-2015-02029, NCT02399228
A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
Status: Active
Phase: Phase II
Type: Prevention, Supportive care
Age: 18 and over
Trial IDs: GT-201, NCI-2015-02173, NCT02508389
Low-Level Laser Therapy in Preventing Oral Mucositis in Patients Receiving Chemotherapy and Radiation Therapy for Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Prevention, Supportive care, Treatment
Age: 18 and over
Trial IDs: 2015-170, NCI-2016-00406, NCT02723604
Laser Surgery or Electrocautery Surgery in Improving Pain and Quality of Life in Patients with Precancerous or Early Stage Oral Cancer
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 11-034, NCI-2011-00924, NCT01355926
Tacrolimus and Methotrexate with or without Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host-Disease in Patients with Hematological Malignancy Undergoing Donor Stem Cell Transplant
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 70 and under
Trial IDs: CASE 6Z13, NCI-2013-01800, NCT01951885
Individualized High Dose Methotrexate in Treating Younger Patients With Cancer and Significant Risk for Side Effects
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 1 to 22
Trial IDs: H-33119, NCI-2014-00923, NCT02076997
Pregabalin in Reducing Mucositis Pain in Patients with Oropharyngeal Cancer Undergoing Chemoradiation Therapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: UPCC 43313, NCI-2014-02239, 43313, 819266, NCT02277548
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients with Head and Neck Cancer
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: I 247213, NCI-2015-00823, NCT02474095
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients with Stage II-IV Head and Neck Cancer during Chemoradiation
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: I 262314, NCI-2015-01338, NCT02531906
Expiratory Muscle Strength Training in Treating Patients with Dysphagia after Head and Neck Radiation Therapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 2015-0238, NCI-2016-00174, NCT02662907
Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 to 65
Trial IDs: CASE6Z14, NCI-2015-00477, NCT02590107
Start Over